Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07419425 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

My Path to Quit Tobacco

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Start date changed from estimate of Jul 2026 to Jul 6, 2026v4
  2. Notable Recruitment opened
    • Start date: Jun 2026 to Jul 2026
    • Site details revised at 5 of 5 sites
    v3
  3. Minor Site details revised at 1 of 5 sites
    • Eligibility criteria expanded, about 1 word
    v2
  4. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The overarching goal of this program of research is to reduce smoking-related health disparities by increasing smoking cessation among Black adults. The goal of this research proposal is to determine whether more intensive, culturally specific, evidence-based interventions are more effective at promoting long-term cessation and other key patient-centered outcomes compared to the usual evidence-based standard of care: services provided by a state-run quitline. This study compares the relative effectiveness of three different treatments (Standard, Intensive, and Intensive Incentivized) on long-term smoking cessation (biochemically confirmed abstinence from combusted tobacco at 26-weeks post-target quit day) among Black adults who smoke and want to quit.
Trial Details
NCT Number NCT07419425
Lead Sponsor University of Wisconsin, Madison
Collaborators: Patient-Centered Outcomes Research Institute
Conditions
(from sponsor)
Smoking Cessation
Related terms Smoking Cessation
Enrollment 1,550 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov